Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) has resulted in a global pandemic. Hydroxychloroquine±azithromycin have been widely used to treat coronavirus disease 2019 (COVID-19) despite a paucity of evidence regarding efficacy. The incidence of torsade de pointes rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Moussa, Gabriels, James, Chang, David, Fishbein, Joanna, Qiu, Michael, Mountantonakis, Stavros E., Epstein, Laurence M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668332/
https://www.ncbi.nlm.nih.gov/pubmed/33003964
http://dx.doi.org/10.1161/CIRCEP.120.008937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668332/
https://www.ncbi.nlm.nih.gov/pubmed/33003964
http://dx.doi.org/10.1161/CIRCEP.120.008937

Ejemplares similares